C 
ConvaTec Group CTEC.L · GBp
Health Care · Health Care Equipment & Supplies · LSE · 🇬🇧 United Kingdom
FTSE 100
248.60p
-0.72%
Close of 9 Nov 2026, in pence
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$2.49bn
FY2016FY2025
Net income
$178.7m
FY2016FY2025
Free cash flow
$342.0m
FY2016FY2025
Shareholders' equity
$1.52bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.49bn | $2.29bn | $2.14bn | $2.07bn | $2.04bn | $1.89bn | $1.83bn | $1.83bn | $1.76bn | $1.69bn |
| Gross profit | $1.37bn | $1.28bn | $1.20bn | $1.12bn | $1.12bn | $1.02bn | $955.6m | $977.1m | $951.9m | $909.9m |
| Research and development | $115.4m | $111.7m | $110.0m | $93.1m | $94.5m | $82.4m | $54.8m | $49.9m | $57.8m | $53.0m |
| Operating income | $415.5m | $324.9m | $262.7m | $207.3m | $203.6m | $211.0m | $214.4m | $280.8m | $281.1m | $203.7m |
| Net income | $178.7m | $190.5m | $130.3m | $62.9m | $117.6m | $112.5m | $9.8m | $221.6m | $158.4m | −$202.8m |
| Diluted earnings per share | 0.09 | 0.09 | 0.06 | 0.03 | 0.06 | 0.06 | 0.00 | 0.12 | 0.08 | -0.10 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.78bn | $3.52bn | $3.71bn | $3.59bn | $3.67bn | $3.77bn | $3.61bn | $3.66bn | $3.80bn | $3.51bn |
| Cash and short-term investments | $75.0m | $64.7m | $98.3m | $145.8m | $463.4m | $565.4m | $385.8m | $315.6m | $289.3m | $264.1m |
| Total liabilities | $2.26bn | $1.83bn | $2.02bn | $1.98bn | $1.98bn | $2.10bn | $2.05bn | $2.04bn | $2.28bn | $2.27bn |
| Debt | $1.52bn | $1.20bn | $1.31bn | $1.30bn | $1.44bn | $1.55bn | $1.57bn | $1.64bn | $1.82bn | $1.78bn |
| Shareholders' equity | $1.52bn | $1.69bn | $1.69bn | $1.61bn | $1.69bn | $1.67bn | $1.56bn | $1.62bn | $1.52bn | $1.25bn |
| Shares outstanding | 2,009m | 2,057m | 2,055m | 2,049m | 2,028m | 2,016m | 1,981m | 1,917m | 1,917m | 1,985m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $479.9m | $396.2m | $367.4m | $281.7m | $305.9m | $399.5m | $401.8m | $352.0m | $306.6m | $74.9m |
| Capital spending | −$137.8m | −$122.1m | −$129.2m | −$144.2m | −$94.1m | −$86.2m | −$61.4m | −$72.1m | −$82.7m | −$66.5m |
| Free cash flow | $342.0m | $274.1m | $238.2m | $137.5m | $211.8m | $313.3m | $340.4m | $279.9m | $223.9m | $8.4m |
| Dividends paid | −$142.9m | −$130.2m | −$110.7m | −$88.1m | −$85.8m | −$62.9m | −$79.9m | −$74.9m | −$26.3m | −$26.3m |
Latest quarters
By quarter end
| Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.22bn | $1.27bn | $1.18bn | $1.18bn | $1.11bn | $1.09bn | $1.06bn | $527.8m |
| Gross profit | $663.5m | $706.2m | $657.1m | $659.4m | $624.2m | $608.1m | $598.6m | $298.1m |
| Operating income | $177.5m | $224.4m | $179.2m | $175.7m | $149.2m | $125.5m | $137.2m | $49.3m |
| Net income | $53.6m | $70.5m | $104.8m | $111.9m | $78.6m | $74.6m | $55.7m | $27.9m |
| Diluted earnings per share | 0.03 | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | 0.01 |
| Cash from operations | $71.0m | $311.0m | $155.0m | $322.0m | $73.0m | $283.0m | $62.0m | $42.0m |
| Capital spending | −$126.0m | −$64.0m | −$56.0m | −$71.0m | −$50.0m | −$70.0m | −$58.0m | — |
| Free cash flow | −$55.0m | $247.0m | $99.0m | $251.0m | $23.0m | $213.0m | $4.0m | — |
| Total assets | $3.81bn | $3.78bn | $3.77bn | $3.52bn | $3.62bn | $3.71bn | $3.75bn | — |
| Cash and short-term investments | $99.5m | $75.0m | $95.7m | $64.7m | $96.9m | $98.3m | $76.5m | — |
| Debt | $25.1m | $1.42bn | $1.28bn | $1.15bn | $1.35bn | $1.25bn | $1.39bn | — |
| Shareholders' equity | $1.44bn | $1.52bn | $1.81bn | $1.69bn | $1.65bn | $1.69bn | $1.63bn | — |
Financial ratios
Data as of 13 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 55.2% | 56.1% | 56.2% | 53.9% | 55.1% | 53.9% |
| Operating margin | 16.7% | 14.0% | 13.1% | 11.8% | 11.3% | 11.9% |
| Net margin | 7.2% | 8.3% | 6.1% | 3.0% | 5.8% | 5.9% |
| Return on equity | 11.8% | 11.3% | 7.7% | 3.9% | 6.9% | 6.7% |
| Return on assets | 4.7% | 5.4% | 3.5% | 1.8% | 3.2% | 3.0% |
| Free cash flow yield | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Revenue growth | 8.8% | 6.9% | 3.4% | 1.7% | 7.6% | 3.7% |
| Earnings growth | -6.2% | 46.2% | 107.2% | -46.5% | 4.5% | 1048.0% |
| Current ratio | 1.53x | 1.55x | 1.62x | 1.67x | 1.95x | 2.30x |
| Debt to equity | 0.95x | 0.68x | 0.74x | 0.77x | 0.80x | 0.88x |
| Equity ratio | 40.1% | 48.0% | 45.6% | 44.8% | 46.1% | 44.4% |
| Interest coverage | 5.81x | 4.35x | 3.82x | 4.99x | 6.39x | 5.10x |
| R&D as a share of sales | 4.6% | 4.9% | 5.1% | 4.5% | 4.6% | 4.3% |
| Buybacks as a share of market value | 2.3% | -0.1% | -0.3% | -1.0% | -0.6% | -1.8% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 6.3% | 5.6% | 4.2% |
| Operating income | 26.1% | 14.5% | 5.0% |
| Net income | 41.6% | 9.7% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 55.6% | 55.4% | 55.1% | 54.3% |
| Operating margin | 15.5% | 13.5% | 12.6% | 13.2% |
| Net margin | 7.7% | 6.3% | 6.1% | 4.1% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 36.6 | 32.1 | 51.7 | 101.6 | 44.1 | 47.7 | — | 16.3 | 33.5 | -30.5 |
| Price to sales | 2.6 | 2.7 | 3.1 | 3.1 | 2.5 | 2.8 | 2.9 | 2.0 | 3.0 | 3.7 |
Dividends and splits
Per share, in the currency the company pays
Paid for 9 years. Last went ex-dividend on 16 Apr 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.04 | 0.05 | 0.049 | 0.05 | 0.046 | 0.041 | 0.044 | 0.045 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.